Potential doubling times of human squamous carcinomas as measured by vincristine.
D001706:Biopsy; D001943:Breast Neoplasms / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008938:Mitosis / Q000187:drug effects; D009062:Mouth Neoplasms / Q000473:pathology*; D009362:Neoplasm Metastasis; D012888:Skull Neoplasms / Q000473:pathology; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage / Q000494:pharmacology*
D014750:Vincristine